vs
CoastalSouth Bancshares, Inc.（COSO）与Spero Therapeutics, Inc.（SPRO）财务数据对比。点击上方公司名可切换其他公司
CoastalSouth Bancshares, Inc.的季度营收约是Spero Therapeutics, Inc.的1.7倍（$21.3M vs $12.6M），Spero Therapeutics, Inc.净利率更高（250.7% vs 31.7%，领先219.0%）
CoastalSouth Bancshares, Inc.是一家美国区域性银行控股企业，主要通过旗下附属银行开展业务，为美国墨西哥湾沿岸地区的零售客户与中小企业提供存款、消费贷款、商业融资、抵押贷款、财富管理等多元金融服务。
COSO vs SPRO — 直观对比
营收规模更大
COSO
是对方的1.7倍
$12.6M
净利率更高
SPRO
高出219.0%
31.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $21.3M | $12.6M |
| 净利润 | $6.7M | $31.5M |
| 毛利率 | — | — |
| 营业利润率 | 41.2% | — |
| 净利率 | 31.7% | 250.7% |
| 营收同比 | — | 24080.8% |
| 净利润同比 | — | 250.9% |
| 每股收益（稀释后） | $0.54 | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COSOSPRO
| Q4 25 | — | $12.6M | ||
| Q3 25 | $21.3M | $0 | ||
| Q2 25 | $19.9M | $0 | ||
| Q1 25 | — | $12.0K | ||
| Q4 24 | — | $52.0K | ||
| Q3 24 | — | $65.0K | ||
| Q2 24 | — | $114.0K | ||
| Q1 24 | — | $140.0K |
净利润COSOSPRO
| Q4 25 | — | $31.5M | ||
| Q3 25 | $6.7M | $-7.4M | ||
| Q2 25 | $6.0M | $-1.7M | ||
| Q1 25 | — | $-13.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-17.1M | ||
| Q2 24 | — | $-17.9M | ||
| Q1 24 | — | $-12.7M |
营业利润率COSOSPRO
| Q4 25 | — | — | ||
| Q3 25 | 41.2% | — | ||
| Q2 25 | 35.4% | — | ||
| Q1 25 | — | -122758.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -28604.6% | ||
| Q2 24 | — | -16720.2% | ||
| Q1 24 | — | -9987.1% |
净利率COSOSPRO
| Q4 25 | — | 250.7% | ||
| Q3 25 | 31.7% | — | ||
| Q2 25 | 30.0% | — | ||
| Q1 25 | — | -115550.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -26380.0% | ||
| Q2 24 | — | -15668.4% | ||
| Q1 24 | — | -9049.3% |
每股收益（稀释后）COSOSPRO
| Q4 25 | — | $0.56 | ||
| Q3 25 | $0.54 | $-0.13 | ||
| Q2 25 | $0.57 | $-0.03 | ||
| Q1 25 | — | $-0.25 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.32 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $40.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $250.4M | $59.0M |
| 总资产 | $2.3B | $68.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COSOSPRO
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | — | $63.5M | ||
| Q1 24 | — | $82.3M |
股东权益COSOSPRO
| Q4 25 | — | $59.0M | ||
| Q3 25 | $250.4M | $26.5M | ||
| Q2 25 | $209.4M | $32.8M | ||
| Q1 25 | — | $33.8M | ||
| Q4 24 | — | $46.1M | ||
| Q3 24 | — | $65.5M | ||
| Q2 24 | — | $80.5M | ||
| Q1 24 | — | $96.2M |
总资产COSOSPRO
| Q4 25 | — | $68.9M | ||
| Q3 25 | $2.3B | $54.2M | ||
| Q2 25 | $2.2B | $62.1M | ||
| Q1 25 | — | $77.7M | ||
| Q4 24 | — | $110.5M | ||
| Q3 24 | — | $135.2M | ||
| Q2 24 | — | $149.9M | ||
| Q1 24 | — | $167.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.5M | $-8.4M |
| 自由现金流经营现金流 - 资本支出 | $-5.9M | — |
| 自由现金流率自由现金流/营收 | -27.7% | — |
| 资本支出强度资本支出/营收 | 1.9% | — |
| 现金转化率经营现金流/净利润 | -0.82× | -0.26× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流COSOSPRO
| Q4 25 | — | $-8.4M | ||
| Q3 25 | $-5.5M | $17.4M | ||
| Q2 25 | $-16.8M | $-17.7M | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $-23.4M | ||
| Q3 24 | — | $12.8M | ||
| Q2 24 | — | $-18.7M | ||
| Q1 24 | — | $5.9M |
自由现金流COSOSPRO
| Q4 25 | — | — | ||
| Q3 25 | $-5.9M | — | ||
| Q2 25 | $-17.9M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率COSOSPRO
| Q4 25 | — | — | ||
| Q3 25 | -27.7% | — | ||
| Q2 25 | -90.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度COSOSPRO
| Q4 25 | — | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 5.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率COSOSPRO
| Q4 25 | — | -0.26× | ||
| Q3 25 | -0.82× | — | ||
| Q2 25 | -2.82× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
